Weight loss with Semaglutide and Tirzepatide can vary, but clinical studies have shown promising results. On average, patients taking Semaglutide can expect to lose between 10% and 15% of their initial body weight in the first year of treatment. With Tirzepatide, some studies have reported weight losses of up to 20% or more. However, it is important to remember that results may vary and that these medications are most effective when combined with a healthy diet and regular exercise.

Both Semaglutide and Tirzepatide have been approved by the FDA for the long-term treatment of obesity and have demonstrated favorable safety profiles in clinical studies. However, as with any medication, side effects can occur and regular medical follow-up is required. Long-term safety is still being studied, and your doctor will closely monitor your progress and adjust treatment as needed.

Although these medications can help reduce appetite, they are not a magic bullet and work best when combined with a healthy lifestyle. A “strict” diet is not required, but we do recommend making healthy food choices and practicing portion control. We will work with you to develop a balanced eating plan that is tailored to your preferences and needs, thereby maximizing the benefits of the medication and promoting sustainable weight loss.

As with any medication, Semaglutide and Tirzepatide may cause side effects. The most common are usually gastrointestinal and include:
*Nausea
*Diarrhoea
*Vomiting
*Constipation

These effects are usually mild to moderate and tend to diminish over time. Rarely, more serious side effects may occur. It is important to discuss all possible side effects with your doctor and report any unusual symptoms during treatment.

Absolutely! In fact, regular exercise is highly recommended while taking these
medications. Exercise can not only improve weight loss results, but it also offers numerous overall health benefits. These medicines do not interfere with your ability to exercise. However, it’s important to start gradually if you’re not used to exercising regularly, and always check with your doctor before starting a new exercise regimen, especially if you have pre-existing health conditions.

If you stop taking Semaglutide or Tirzepatide, you may experience an increased appetite and potentially regain some of the lost weight. However, the amount of weight that is regained can vary from person to person and depends largely on your eating and exercise habits after stopping the medication. That’s why we emphasize the importance of developing sustainable healthy lifestyle habits during treatment. If you’re considering stopping the medication, it’s crucial to discuss it with your doctor first to develop a proper transition plan.

Semaglutide and Tirzepatide may interact with some medications, especially those used to treat diabetes. It is crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking before starting treatment. Your doctor will carefully review your medical history and medication list to make sure these treatments are safe for you and adjust doses as needed to avoid potentially dangerous interactions.

The length of treatment may vary depending on your weight loss goals and your individual response to the medication. Many patients continue treatment for at least a year to reach and maintain their goal weight. However, these drugs are approved for long-term use in the management of chronic obesity. Your doctor will work with you to determine the optimal length of treatment based on your progress and long-term health goals.

Although Semaglutide and Tirzepatide are effective for weight loss, they are not suitable for everyone. They are generally recommended for adults with a body mass index (BMI) of 30 or higher (obesity), or 27 or more (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol. In addition, there are certain medical conditions and situations in which these medications may not be appropriate. It is essential to have a full medical evaluation to determine if these treatments are suitable and safe for you.

Both Semaglutide and Tirzepatide are given by injection subcutaneously (under the skin) once a week. Injections are usually done in the abdomen, thigh, or upper arm. We’ll provide you with detailed instructions on how to administer the injection correctly and practice together to make sure you’re comfortable with the process. Many patients find the injections to be relatively painless and easy to administer after a little practice.